Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0000950170-24-026365

Chief Operating Officer sold 9,152 shares at an average $20.06 ($183,568)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bensen Daniel Chief Operating Officer 2024-03-01 Sale 10b5-1 −2,900 $20.04 $58,112 439,936 D
Bensen Daniel Chief Operating Officer 2024-03-04 Sale 10b5-1 −5,063 $20.08 $101,654 434,873 D
Bensen Daniel Chief Operating Officer 2024-03-05 Sale 10b5-1 −1,189 $20.02 $23,802 433,684 D
Open-market sales · 9,152 sh · avg $20.06 · $183,568
Loading xslF345X05/ownership.xml…